// App-Quantinova.ai

FRI0036 : VALIDATION OF RISK SCORES FOR PREDICTING PROGRESSION IN INDIVIDUALS “AT RISK OF RHEUMATOID ARTHRITIS”

Researchers

Presenter

  • L. Duquenne

Principal Investigators

  • J. Nam

  • K. Mankia

  • L. Garcia-Montoya

  • A. DI Matteo

  • P. Emery

Medical Centers

  • Leeds Biomedical Research Centre, NIHR, Leeds, United Kingdom

  • University of Leeds, Leeds Institue of Rheumatic and Musculoskeletal Medicine, Leeds, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • anti-CCP antibodies

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Observational

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved